glp 1 drugs depression Transformation 2.0: The GLP-1 RAs as Psychiatric Medications? GLP-1 Receptor Agonists in Mood

Fact : Actually, these drugs are very safe as proven by extensive clinical testing

Retrieved 30 May 2026

For example, the SELECT trial clearly demonstrated that semaglutide significantly reduces the risk of major adverse cardiovascular events (MACE), leading to FDA approval for lowering the risk of cardiovascular death, myocardial infarction, or stroke in overweight or obese adults with established cardiovascular disease (Lincoff et al., 2023

The Beneficiaries of GLP-1 Drugs Across Industries Health Insurers and the Cost of Obesity Source: McKinsey 4 Although weight loss has been the main focus in the analyses of these drugs so far, it is important to bear in mind that with them comes the improvement in other measurements of health, such as blood glucose levels, cardiovascular parameters, cholesterol and triglyceride levels

Are you on a steady routine, or are you still titrating and managing side effects that could complicate screening